This article is more than 5 years old. Information may no longer be current.

Debating the merits of dropless cataract surgery

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CEDARS Debates is a monthly feature in Ocular Surgery News. CEDARS — Cornea, External Disease, and Refractive Surgery Society — is a group of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

As the price of perioperative eye drops continues to rise and the push toward generic drops grows, surgeons are faced with a battle to ensure that their patients obtain the medications needed to enhance surgical outcomes. They also need to ensure that patients actually comply with their postoperative regimen. Patients now struggle with the ever-rising prices of these medications and often are unable to obtain the drops the surgeon suggests. Recently, there has been an emergence of injectable medications to allow dropless cataract surgery. This month, Dr. Keith Walter and CEDARS guest Dr. Alice Epitropoulos discuss the benefits of dropless cataract surgery. We hope you enjoy this discussion.

Click here to read the full publication exclusive, CEDARS Debate, published in Ocular Surgery News U.S. Edition, December 25, 2014.